Insmed Incorporated Common Stock (INSM)

About INSM

Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory nontuberculous mycobacterial lung infections, as well as is in phase 3 clinical trial for the treatment of mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

1,664

Website

insmed.com/

Fundamentals

1-day range

$117.15$120.66

Market cap

$21.34B

P/E (trailing)

—

P/E (forward)

147.76

EPS (trailing)

$-4.10

Dividend yield

—

Beta

0.83

Avg. volume

3.44M

Forecasts

22 analyst ratings

Insmed Incorporated Common Stock Competitors

Chosen by industry and closest market cap.

• INSM

  Insmed Incorporated Common Stock

  $118.52

  ▼ 2.36%
  Market cap $21.34BP/E —
  $90.39$212.75
• UTHR

  United Therapeutics Corporation Common Stock

  $515.57

  ▼ 2.34%
  Market cap $21.92BP/E 17.03
  $302.19$609.35
• VTRS

  Viatris Inc. Common Stock

  $16.34

  ▼ 3.26%
  Market cap $20.53BP/E —
  $9.43$18.39
• ROIV

  Roivant Sciences Ltd. Common Shares

  $34.71

  ▼ 7.64%
  Market cap $24.08BP/E —
  $11.85$37.97
• JAZZ

  Jazz Pharmaceuticals plc Common Stock (Ireland)

  $244.6

  ▼ 2.59%
  Market cap $15.80BP/E 16.97
  $123.88$266.38
• BBIO

  BridgeBio Pharma Inc. Common Stock

  $76.62

  ▼ 2.62%
  Market cap $15.65BP/E —
  $48.78$93.42
• ASND

  Ascendis Pharma A/S Ordinary Share

  $248.06

  ▼ 0.52%
  Market cap $15.09BP/E 26.94
  $186.05$282.15

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• If You Invested $1000 In Insmed Stock 10 Years Ago, You Would Have This Much Today
  benzinga · 8/28/2026
• If You Invested $1000 In Insmed Stock 10 Years Ago, You Would Have This Much Today
  Benzinga · 8/28/2026
• Alger Mid Cap 40 ETF Q2 2026 Portfolio Review
  SeekingAlpha · 8/25/2026
• Invesco Discovery Mid Cap Growth Fund Q2 2026 Portfolio Performance
  SeekingAlpha · 8/23/2026
• Biotech Is Booming, But These 2 Stocks Missed the Memo
  Benzinga · 8/20/2026
• Artisan Global Opportunities Fund Q2 2026 Portfolio Review
  SeekingAlpha · 8/19/2026
• Alger Small Cap Growth Fund Q2 2026 Portfolio Review
  SeekingAlpha · 8/14/2026
• Insmed (INSM) Q2 2026 Earnings Call Transcript
  Yahoo · 8/13/2026
• American Century Focused Dynamic Growth Fund Q2 2026 Portfolio Review
  SeekingAlpha · 8/11/2026

• Roger Adsett · August 10, 2026 · Option Exercise

  81.0K @ $30.46
• Roger Adsett · August 10, 2026 · Option Exercise

  76.6K @ $17.16
• Roger Adsett · August 10, 2026 · Option Exercise

  82.3K @ $13.67
• Roger Adsett · August 10, 2026 · Sale

  239.8K @ $133.27
• Martina M.D. Flammer · August 6, 2026 · Option Exercise

  8.9K @ $25.83
• Martina M.D. Flammer · August 6, 2026 · Option Exercise

  18.3K @ $18.95
• Martina M.D. Flammer · August 6, 2026 · Sale

  18.3K @ $129.4
• Martina M.D. Flammer · August 6, 2026 · Sale

  8.9K @ $127
• William Lewis · July 23, 2026 · Option Exercise

  4.4K @ $17.16
• William Lewis · July 23, 2026 · Option Exercise

  6.3K @ $30.46
• William Lewis · July 23, 2026 · Sale

  5.9K @ $106.43
• William Lewis · July 23, 2026 · Sale

  4.8K @ $105.62
• William Lewis · July 9, 2026 · Option Exercise

  4.4K @ $17.16
• William Lewis · July 9, 2026 · Option Exercise

  6.3K @ $30.46
• William Lewis · July 9, 2026 · Sale

  3.4K @ $118.52

Institutional Ownership

March 31, 2026

Total shares held

183.14M

Total value held

$28.58B

Institutional holders

663